Dimensional Fund Advisors LP increased its stake in shares of Omega Protein Co. (NYSE:OME) by 0.3% in the third quarter, HoldingsChannel.com reports. The firm owned 1,890,506 shares of the company’s stock after buying an additional 6,523 shares during the quarter. Dimensional Fund Advisors LP owned 0.08% of Omega Protein worth $31,477,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Parametric Portfolio Associates LLC grew its stake in shares of Omega Protein by 21.8% during the second quarter. Parametric Portfolio Associates LLC now owns 259,541 shares of the company’s stock worth $4,646,000 after purchasing an additional 46,383 shares during the period. Shell Asset Management Co. acquired a new stake in shares of Omega Protein during the third quarter worth $2,052,000. Citadel Advisors LLC grew its stake in shares of Omega Protein by 139.5% during the third quarter. Citadel Advisors LLC now owns 44,918 shares of the company’s stock worth $748,000 after purchasing an additional 26,161 shares during the period. Icon Advisers Inc. Co. acquired a new stake in shares of Omega Protein during the second quarter worth $304,000. Finally, OxFORD Asset Management LLP grew its stake in shares of Omega Protein by 118.9% during the second quarter. OxFORD Asset Management LLP now owns 109,291 shares of the company’s stock worth $1,956,000 after purchasing an additional 59,365 shares during the period. 85.81% of the stock is owned by institutional investors and hedge funds.

Shares of Omega Protein Co. (OME) opened at $22.00 on Tuesday. Omega Protein Co. has a 52 week low of $14.50 and a 52 week high of $26.99. The company has a market capitalization of $494.54, a price-to-earnings ratio of 26.83 and a beta of 0.28.

Omega Protein (NYSE:OME) last announced its quarterly earnings data on Wednesday, November 8th. The company reported $0.09 EPS for the quarter, missing analysts’ consensus estimates of $0.31 by ($0.22). Omega Protein had a return on equity of 6.48% and a net margin of 5.45%. The company had revenue of $90.30 million for the quarter, compared to analyst estimates of $96.65 million. During the same period last year, the firm earned $0.67 earnings per share. The firm’s revenue for the quarter was down 17.0% on a year-over-year basis.

Separately, ValuEngine raised Omega Protein from a “hold” rating to a “buy” rating in a research note on Monday, October 2nd.

ILLEGAL ACTIVITY NOTICE: This report was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another website, it was illegally stolen and republished in violation of U.S. & international copyright law. The correct version of this report can be read at https://www.thecerbatgem.com/2018/01/16/dimensional-fund-advisors-lp-has-31-48-million-position-in-omega-protein-co-ome.html.

Omega Protein Profile

Omega Protein Corporation is a nutritional products company that develops, produces and delivers nutritious products. The Company operates through two segments: animal nutrition and human nutrition. The Company’s animal nutrition segment consists of two subsidiaries: Omega Protein, Inc (Omega Protein) and Omega Shipyard, Inc (Omega Shipyard).

Want to see what other hedge funds are holding OME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Protein Co. (NYSE:OME).

Institutional Ownership by Quarter for Omega Protein (NYSE:OME)

Receive News & Ratings for Omega Protein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Protein and related companies with MarketBeat.com's FREE daily email newsletter.